CJC-1295 Storage & Handling Guide

CJC-1295 comes in two distinct forms, no-DAC and DAC, so the first concern in handling it is knowing exactly which material is in front of you. This guide covers storage and handling only. The product specification supplied with the vial on the CJC-1295 product page states the conditions to follow.

What sets CJC-1295 apart from a single-form peptide is the chance of confusing two variants. On receipt, checking that the label and identifiers name the no-DAC form, that they match the accompanying documentation, and that the packaging is intact, removes that risk before the material is ever stored. Where a certificate of analysis is supplied, our guide to reading a certificate of analysis explains how to relate it to the vial, and research material specifications covers how form and purity are stated.

Analytically, the two forms differ by the Drug Affinity Complex group present on the DAC variant and absent here, a difference that shows up as a change in mass. A certificate of analysis or a mass measurement matching the no-DAC sequence is the clearest confirmation, and recording that confirmation next to the batch identifier keeps the distinction unambiguous for anyone using the material later. Where several secretagogue materials are held together, naming the form on the storage label as well as in the records prevents a mix-up at the point of use.

Supplied freeze-dried, CJC-1295 is in its most stable form, and the reasoning behind that is in our note on the freeze-drying process. A sealed vial stays sealed until needed, kept cold per the specification and away from light. A temperature record, from checks or a logger, shows the material stayed within range; the general framework, including out-of-range events, is in our peptide storage guidelines and temperature excursion management notes.

For an analogue defined partly by its stability modifications, the dry, cold state is what preserves those properties between receipt and study, so the condition on the specification is applied from the moment the vial arrives. Returning the vial to that condition promptly after each access, rather than leaving it out, keeps the analogue in the state its characterisation assumed. A short equilibration to room temperature is expected before opening; an extended spell at ambient is not.

Once a cold vial has reached room temperature while sealed, brief and tidy handling with a prompt reseal limits the moisture reaching the powder. Whether and how the material is taken into solution belongs to the study protocol, so no solvent or concentration is set here; general background is in reconstitution considerations, and the common avoidable slips are in common laboratory storage mistakes.

For a material with two forms, records that name the form alongside the batch identifier keep the trail unambiguous. Logging receipt, storage conditions, the batch identifier and each access ties any observation to a specific vial; the practices are in batch identification and sample traceability. The science behind CJC-1295 is in the CJC-1295 research overview, with the wider range in the research catalogue.

All products are supplied strictly for laboratory research use only. Not for human or animal consumption. Not a drug, supplement, or food. Not for diagnostic or therapeutic use. The material on this page is educational and factual: it summarises areas of published scientific investigation and general laboratory practice. It is not guidance for the use of any material in humans or animals, and nothing here should be read as a claim about safety, performance, or outcomes. Where a specific product specification or safety data sheet is provided with a material, that document is the definitive reference and takes precedence over any general information given here.